NCT06621680

Brief Summary

This study will be conducted to investigate the effect of connective tissue massage on premenstrual syndrome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 1, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

October 10, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2025

Completed
Last Updated

October 1, 2024

Status Verified

September 1, 2024

Enrollment Period

6 months

First QC Date

September 29, 2024

Last Update Submit

September 29, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain intensity

    Degrees of menstrual pain will be assessed using a VAS for all participants before and after treatment, which is a method of representing pain on a 10 cm linear scale. A score of zero means "No pain" and 10 means "a very high degree of pain".

    3 months

  • Premenstrual syndrome severity

    Severity of premenstrual symptoms will be assessed by using the Menstrual Distress Questionnaire (MDQ). Each participant will examine symptom categories (pain, concentration, water retention, behavior changes, negative effect, autonomic reaction, arousal and control) Participants are asked to report the symptoms experienced during their most recent menstrual period, using a rating scale. Responses ranged from (0) No experience of the symptom, (1) mild, (2) moderate, (3) severe and (4) very severe disabling symptoms. Overall scores are interpreted as follows: \>50- mild, 50 to 70- moderate and \>70 severe

    3 months

Study Arms (2)

Multivitamins group

ACTIVE COMPARATOR

This group will receive multivitamins capsule once daily, for 12 weeks.

Drug: Multivitamins

Connective tissue massage group

EXPERIMENTAL

This group will receive multivitamins in addition to connective tissue massage on (Sacral, lumbar, last thoracic vertebrae-T12, and subcostal regions), 2 sessions/week, 20 minutes/ session for 12 weeks

Drug: MultivitaminsOther: Connective tissue massage

Interventions

All participants will receive multivitamins (vitatron) capsule once daily, for 12 weeks.

Connective tissue massage groupMultivitamins group

Connective tissue massage will be applied on (Sacral, lumbar, last thoracic vertebrae-T12, and subcostal regions), 2 sessions/week for 20 minutes each session for 12 weeks. Treatment will begin 3 days before menstruation to the 4th day of menstruation for 3 successive menstrual cycles.

Connective tissue massage group

Eligibility Criteria

Age17 Years - 25 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Virgin adolescent females diagnosed with premenstrual syndrome.
  • Their age will be ranged from 17-25 years (3 years post puberty).
  • Their body mass index (BMI) will be less than 30 kg/m2 .
  • All are of regular menstrual cycles.
  • All of them suffering from moderate and severe PMS.

You may not qualify if:

  • Participants will be excluded from this study if they have
  • Any pathological finding in the pelvic cavity as polycystic ovarian syndrome, endometriosis, and pelvic inflammatory diseases.
  • Irregular menstruation.
  • Any history of gynecological intervention.
  • Open wounds, weak/broken bones or fractures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Enas Nabil Georgy

Giza, Egypt

Location

MeSH Terms

Conditions

Premenstrual Syndrome

Interventions

Geritol

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Azza B Kassab, professor

    Cairo University

    STUDY CHAIR

Central Study Contacts

Enas N Georgy, Master

CONTACT

Mohamed F Abo Eleinien, professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 29, 2024

First Posted

October 1, 2024

Study Start

October 10, 2024

Primary Completion

April 1, 2025

Study Completion

April 15, 2025

Last Updated

October 1, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations